Personalis, Inc. (PSNL)
6.73
+0.07
(+1.05%)
USD |
NASDAQ |
Apr 17, 16:00
6.725
0.00 (0.00%)
After-Hours: 20:00
Personalis Research and Development Expense (Quarterly) : 13.07M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 86.27M |
| Celldex Therapeutics, Inc. | 74.52M |
| Plus Therapeutics, Inc. | 2.941M |
| Atossa Therapeutics, Inc. | 6.156M |
| Abeona Therapeutics, Inc. | 5.849M |